Rafael Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Rafael Holdings, Inc. (RFL) on September 14, 2021, reporting events occurring on September 10 and September 13, 2021. The filing addresses significant changes in the company's executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and personnel changes.
Material Changes
- Departure: David Polinsky resigned as Chief Financial Officer effective September 13, 2021.
- Appointment: Patrick Fabbio was elected Chief Financial Officer by the Board of Directors on September 10, 2021, effective September 13, 2021.
- Compensation Package: A Letter Agreement was executed with Mr. Fabbio detailing the following terms:
- Annual base salary: $425,000.
- Signing bonus: $50,000.
- Annual target performance bonus: 40% of base salary.
- Initial stock option grant: Valued at $2,500,000, vesting over four years (25% on the first anniversary, then monthly thereafter).
- Severance provisions: 3 months' base salary for termination without cause/resignation for good reason within the first year; 6 months' base salary after the first year; 12 months' base salary if termination occurs within six months of a Change of Control.
Outlook, Risks, and Management Commentary
The filing includes a biographical summary of Patrick Fabbio, noting his prior roles as CFO at WindMIL Therapeutics Inc., Progenics Pharmaceuticals, Inc., and electorCore Medical, LLC, as well as his experience at NPS Pharmaceuticals, Inc. He holds a BBA and MBA from New York University and is a Certified Public Accountant. No specific forward-looking guidance, risk factors, or unusual items regarding the company's operations were disclosed in this specific report.
Investor Verification Checklist
- Verify the full terms of the Letter Agreement (Exhibit 10.01) for any additional clauses not summarized in the text.
- Review the press release (Exhibit 99.1) for broader context on the leadership transition.
- Confirm the vesting schedule specifics for the $2.5 million stock option grant.
- Monitor future filings for the impact of this leadership change on financial reporting and strategic direction.